Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 349M | 300M |
| Research and development | 15M | 19M |
| Selling, general and administrative | 64M | 53M |
| Operating expenses | 342M | 279M |
| Operating income | 7M | 21M |
| Pre-tax income | −16M | 5M |
| Income tax | −53M | −9M |
| Net income | 4M | 561,000 |
| Earnings per share | 0.15 | 0.02 |
| Earnings per share, diluted | 0.15 | 0.02 |
| Weighted average shares | 28M | 28M |
| Weighted average shares, diluted | 29M | 28M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 133M | 24M | 30M | 29M | 40M | 24M | 24M | 22M |
| Short-term investments | — |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | 36M | 31M |
| Depreciation and amortisation | 22M | 18M |
| Share-based compensation | 6M | 6M |
| Capital expenditure | 71M | 127M |
| Investing cash flow | −77M | −135M |
| Financing cash flow | 42M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| — |
| — |
| 0 |
| 11M |
| 9M |
| Receivables | 43M | 62M | 31M | 29M | 31M | 47M | 40M | 24M |
| Current assets | 213M | 123M | 123M | 123M | 116M | 117M | 123M | 105M |
| Goodwill | 55M | 55M | 55M | 55M | 55M | 55M | 55M | 55M |
| Total assets | 1.06B | 959M | 917M | 906M | 885M | 881M | 831M | 782M |
| Current liabilities | 97M | 104M | 83M | 98M | 102M | 104M | 98M | 81M |
| Total liabilities | 549M | 462M | 434M | 432M | 420M | 416M | 361M | 328M |
| Equity | 8M | −13M | 7M | −22M | 58M | −148M | −179M | −273M |
| Treasury shares | — | — | 2M | 2M | 2M | 2M | 2M | 2M |
| 84M |